Original scientific paper
Human Papilloma Virus Vaccination Knowledge, Prevalence, Risk Factors, and HPV Detection in 18-26 and 27-45-year-old Men and Women
Pavel V. Chernyshov
orcid.org/0000-0001-7275-4651
; Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine;
Tetiana Semushyna
; MUS “Kyiv City Perinatal Center”, Kiev, Ukraine
Liudmyla Verbytska
; Sports Medicine Center of Kyiv, Kiev, Ukraine
Pavlo V. Fedorych
; Ukrainian Military Medical Academy, Kyiv, Ukraine
Anna Avramenko
; Kiev Maternity Hospital 5, Kiev, Ukraine
Tetiana Osaulenko
; Obstetrics and gynecology, Private practice, Kiev, Ukraine
Yulia V. Zolotonosha
; Kyiv Miska Klinichna Likarnya 18, Kiev, Ukraine
Abstract
The US Food and Drug Administration approved a supple-
mental application for HPV 9-valent vaccine for 27-45-year-old women
and men. The Advisory Committee on Immunization Practices did not
recommend catch-up vaccination of adults aged 27-45 years, but rec-
ognized that some adults who were not previously vaccinated may be
at risk for new HPV infection and might benefit from vaccination in this
age range. We decided to compare HPV vaccination knowledge, preva-
lence, risk factors, and history of HPV detection in cohorts with ages of
18-26 and 27-45 years. Men and women aged 18-45 years were asked
to complete an anonymous internet survey about HPV infection and
vaccination. Valid answers were received from 524 respondents. HPV
vaccination rates were low (from 0.00 to 5.56%). All women aged 27-45
years bought the vaccine at their own cost and were vaccinated after
sexual debut. Knowledge on existence of the HPV vaccine was better
in women (P<0.01). The overall number of sexual partners was signifi-
cantly higher in men and in persons aged 27-45 (P<0.05). Women aged
27-45 reported higher prevalence of unprotected vaginal and anal
sex, a higher number of sexual partners, and lower HPV-related cancer
awareness. Our study showed that better knowledge on HPV vaccina-
tion and HPV-related cancer awareness did not lead to higher HPV vac-
cination rates. A substantial number of individuals aged 27-45 years
may benefit from HPV vaccination, and information on HPV vaccina-
tion should be actively disseminated by physicians and mass media.
Keywords
human papilloma virus; vaccination; knowledge; risk factors; HPV detection
Hrčak ID:
299661
URI
Publication date:
14.12.2022.
Visits: 430 *